Stopping Cancer Early – The Best Possible Investment

Finding cancer earlier, more accurately and cost effectively.
It’s about time.

Early Cancer Detection = Canary Solution

For over 10 years, Canary has been the only foundation in the world focused solely on early cancer detection. Learn More »

Accomplishments & Milestones

See Canary’s progress in early cancer detection solutions.

Past
Present
Future
2000

Don Listwin’s mother, Grace Listwin, misdiagnosed with bladder infection

2001

Grace Listwin dies of late-stage ovarian cancer due to detection of her cancer at a late stage

2002

Ovarian cancer biomarker work for Dr. Nicole Urban funded by Listwin Family Foundation at the Fred Hutch Cancer Research Center (FHCRC) in Seattle

2003

Center of Excellence for early cancer detection established by Dr. Lee Hartwell at FHCRC focusing on cancer biomarkers

First Canary science team formed—ovarian cancer

2004

Canary Foundation formed by Don Listwin

2005

Second Canary science team formed—pancreatic cancer

First annual Scientific Symposium

2006

Discovery of gene mutation in pancreatic cancer

Partnership with Canadian British Columbia Cancer Agency to build antibodies and assays for blood biomarkers

2007

Two more Canary science teams formed—prostate and lung

Microbubble-based molecular imaging studies

2008

Prostate Active Surveillance Study (PASS) enrolls first patients

Canary ovarian team conducts preclinical validation of ovarian biomarker HE4

2009

Founded Canary Center at Stanford with Stanford School of Medicine and Stanford Cancer Institute

Canary ovarian team launches Novel Markers Trial

Magneto-nano sensor developed to detect biomarkers—10,000 times more sensitive than existing tests

2009Continued

Never Smokers Lung Cancer Study launches

Don Listwin named to National Cancer Institute Board of Scientific Advisors

2010

Lung cancer imaging trial begins at Stanford

Stanford team builds photoacoustic device for prostate cancer (begins testing in 2011)

Parag Mallick & Sharon Pitteri hired—first full-time faculty at Stanford dedicated 100% to early cancer detection

2011

Gene fusion discovered for ovarian cancer

Canary pancreatic cancer team demonstrates microbubble imaging to below 1 mm in size

Canary lung cancer team discovers novel biomarker that defines patients as high-risk

2012

Breast Cancer Program launched

Stanford Cancer Institute Awards Canary Foundation with Spirit of Hope Award

2013

Stanford moves Canary Center to Stanford’s Technology and Innovation Park—2x lab space

Genomic Health partners with PASS team to work on detection test for prostate cancer

Microbubble clinical trials in ovarian and breast cancer begin in Rome

2014

FDA approves ultrasound using microbubble—trials begin for men with prostate cancer at Stanford

Canary prostate cancer team—PASS wins competitive NCI award

Partnership with MD Anderson to build national lung cancer screening trial

2014Continued

Clinical trials begin in partnership with El Camino Hospital for pancreatic early cancer detection

Canary Center recruits Utkan Demirci from Harvard/MIT with expertise in biomedical microfluidic technology platforms

 

2014Continued

CRUK launches early cancer detection initiatives in UK

OHSU launches billion-dollar early detection initiative

2015

Tom Soh recruited from UCSB—focusing on portable, rapid, and sensitive diagnostic platforms

Canary develops Canary Quantum Cloud to give researchers access to new machine-learning platform

Five-Year Goals

Ovarian cancer biomarkers go to all national high-risk clinics

Microbubble technology approved for breast cancer

Microbubble approved for pancreatic cancer

Five-Year GoalsContinued

Photoacoustics imaging trials in prostate and ovarian cancers concluded and move to national high-risk clinics

Prostate prognostic test available commercially

International lung cancer biomarker trial ongoing

2000

Don Listwin’s mother, Grace Listwin, misdiagnosed with bladder infection

2001

Grace Listwin dies of late-stage ovarian cancer due to detection of her cancer at a late stage

2002

Ovarian cancer biomarker work for Dr. Nicole Urban funded by Listwin Family Foundation at the Fred Hutch Cancer Research Center (FHCRC) in Seattle

2003

Center of Excellence for early cancer detection established by Dr. Lee Hartwell at FHCRC focusing on cancer biomarkers

First Canary science team formed—ovarian cancer

2004

Canary Foundation formed by Don Listwin

2005

Second Canary science team formed—pancreatic cancer

First annual Scientific Symposium

2006

Discovery of gene mutation in pancreatic cancer

Partnership with Canadian British Columbia Cancer Agency to build antibodies and assays for blood biomarkers

2007

Two more Canary science teams formed—prostate and lung

Microbubble-based molecular imaging studies

2008

Prostate Active Surveillance Study (PASS) enrolls first patients

Canary ovarian team conducts preclinical validation of ovarian biomarker HE4

2009

Founded Canary Center at Stanford with Stanford School of Medicine and Stanford Cancer Institute

Canary ovarian team launches Novel Markers Trial

Magneto-nano sensor developed to detect biomarkers—10,000 times more sensitive than existing tests

2009 Continued

Never Smokers Lung Cancer Study launches

Don Listwin named to National Cancer Institute Board of Scientific Advisors

2010

Lung cancer imaging trial begins at Stanford

Stanford team builds photoacoustic device for prostate cancer (begins testing in 2011)

Parag Mallick & Sharon Pitteri hired—first full-time faculty at Stanford dedicated 100% to early cancer detection

2011

Gene fusion discovered for ovarian cancer

Canary pancreatic cancer team demonstrates microbubble imaging to below 1 mm in size

Canary lung cancer team discovers novel biomarker that defines patients as high-risk

2012

Breast Cancer Program launched

Stanford Cancer Institute Awards Canary Foundation with Spirit of Hope Award

2013

Stanford moves Canary Center to Stanford’s Technology and Innovation Park—2x lab space

Genomic Health partners with PASS team to work on detection test for prostate cancer

Microbubble clinical trials in ovarian and breast cancer begin in Rome

2014

FDA approves ultrasound using microbubble—trials begin for men with prostate cancer at Stanford

Canary prostate cancer team—PASS wins competitive NCI award

Partnership with MD Anderson to build national lung cancer screening trial

2014 Continued

Clinical trials begin in partnership with El Camino Hospital for pancreatic early cancer detection

Canary Center recruits Utkan Demirci from Harvard/MIT with expertise in biomedical microfluidic technology platforms

 

2014 Continued

CRUK launches early cancer detection initiatives in UK

OHSU launches billion-dollar early detection initiative

2015

Tom Soh recruited from UCSB—focusing on portable, rapid, and sensitive diagnostic platforms

Canary develops Canary Quantum Cloud to give researchers access to new machine-learning platform

Five-Year Goals

Ovarian cancer biomarkers go to all national high-risk clinics

Microbubble technology approved for breast cancer

Microbubble approved for pancreatic cancer

Five-Year Goals Continued

Photoacoustics imaging trials in prostate and ovarian cancers concluded and move to national high-risk clinics

Prostate prognostic test available commercially

International lung cancer biomarker trial ongoing

Happening Now

Catch Cancer Early Help raise $30K by August 30th

Want to make an impact right away? Debbi Spungen and her family are kicking off a special online campaign to catch cancer early.

Inspired by Canary’s vision to “demonstrate efficient, accurate, cost effective tools for cancer early detection,” they have given an anchor gift and are asking you to join them in raising $30K.

Learn More »
Canary Challenge:
Canary Foundation’s Largest Fundraiser
September 26, 2015
Palo Alto, CA

In 2014, the event raised over $1.1 million with 1100 participants. With 5 routes—starting with a family friendly 5krun/walk/ride and going all the way up to the 100 mile Canary Century, this day-long festival has something for everyone.

Learn More »